Growth Metrics

Chemours (CC) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Chemours (CC) over the last 12 years, with Q3 2025 value amounting to $60.0 million.

  • Chemours' Income from Continuing Operations rose 28750.0% to $60.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$339.0 million, marking a year-over-year decrease of 62968.75%. This contributed to the annual value of $70.0 million for FY2024, which is 11256.73% up from last year.
  • Chemours' Income from Continuing Operations amounted to $60.0 million in Q3 2025, which was up 28750.0% from -$380.0 million recorded in Q2 2025.
  • Chemours' Income from Continuing Operations' 5-year high stood at $240.0 million during Q3 2022, with a 5-year trough of -$380.0 million in Q2 2025.
  • Over the past 5 years, Chemours' median Income from Continuing Operations value was $60.0 million (recorded in 2024), while the average stood at $32.5 million.
  • As far as peak fluctuations go, Chemours' Income from Continuing Operations skyrocketed by 34857.14% in 2021, and later plummeted by 73333.33% in 2025.
  • Quarter analysis of 5 years shows Chemours' Income from Continuing Operations stood at $157.0 million in 2021, then tumbled by 161.78% to -$97.0 million in 2022, then soared by 81.44% to -$18.0 million in 2023, then soared by 88.89% to -$2.0 million in 2024, then skyrocketed by 3100.0% to $60.0 million in 2025.
  • Its Income from Continuing Operations stands at $60.0 million for Q3 2025, versus -$380.0 million for Q2 2025 and -$17.0 million for Q1 2025.